Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00092157 | Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224) | PHASE3 | COMPLETED | 571 | — | — | May 1, 2002 | Mar 4, 2003 | Aug 15, 2024 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0733, simvastatin | DRUG | - |
| Comparator: simvastatin | DRUG | - |
Inclusion Criteria: * Elevated cholesterol level Exclusion Criteria: * Liver disease * Known allergies to study drugs